Vimarsana
Biggest News Aggregation in the World

Registrational Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Registrational Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Registrational Program Today - Breaking & Trending Today

CNBC Mad Money January 15, 2015 - Vimarsana News

CNBC Mad Money January 15, 2015

Know the american first people. They wanted to keep us out of foreign wars stay home and build a big moat and today a country famous for cuckoo clocks does something cuckoo sending our markets down s p tumbling and nasdaq plunging 1. 48. Why do i want to come . Let me start with the foreign wars the foreign currency war going on in europe . I dont know where it is this morning. The swiss decided to make the currency stronger versus the euro, one of the necessary but still shocking things that spits land had to do to keep hot money flowing out of euro denominated banks into swiss franc denomina...

U.S. FDA Approves Pfizer's VELSIPITY for Adults with Moderately to Severely Active Ulcerative Colitis (UC) - Vimarsana News

U.S. FDA Approves Pfizer's VELSIPITY for Adults with Moderately to Severely Active Ulcerative Colitis (UC)

13.10.2023 - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely ...

Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Tre - Vimarsana News

Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Tre

AR-15512 is a differentiated, novel, first-in-class product candidate for the treatment of the signs and symptoms of Dry Eye DiseaseCOMET-3 is the second of three studies in the AR-15512 Registrational Phase 3 ProgramDURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company...